NewcelX (NCEL) director reports 9,117 share options vesting through 2035

Rhea-AI Filing Summary

NewcelX Ltd. director Iohan Eran Israel filed an initial Form 3 reporting stock option holdings. He holds an option to purchase 9,117 ordinary shares with an exercise price of $7.62 per share, expiring on November 4, 2035.

As of this filing, options for 759 ordinary shares are vested and currently exercisable. The remaining options vest in 11 equal quarterly installments beginning on May 4, 2026, conditioned on his continued service. The options were issued under NewcelX’s 2021 share option plan and are held through a trustee to qualify for Israeli Section 102 tax benefits.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Iohan Eran Israel

(Last) (First) (Middle)

C/O NEWCELX LTD.

THE CIRCLE 6

(Street)

ZURICH 8058

(City) (State) (Zip)

SWITZERLAND

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
NewcelX Ltd. [ NCEL ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option to Purchase Ordinary Shares	(1)	11/04/2035	Ordinary Shares	9,117(2)	$7.62	D

Explanation of Responses:

1. As of the date of this Form 3, options to purchase 759 ordinary shares are vested and currently exercisable. The remaining options vest and become exercisable beginning on May 4, 2026 in 11 equal installments on a quarterly basis, subject to the Reporting Person's continued service.

2. To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued to an employee in connection with the NewcelX Ltd. Share Option Plan Regulation 2021 must be registered in the name of a trustee.

	/s/ Eran Iohan	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does Iohan Eran Israel report in his NewcelX (NCEL) Form 3?

He reports holding an option to purchase 9,117 NewcelX ordinary shares at an exercise price of $7.62 per share. This Form 3 is an initial statement of beneficial ownership, not a record of recent buying or selling activity.

How many NewcelX (NCEL) stock options are currently vested for Iohan Eran Israel?

As of the Form 3 date, options for 759 ordinary shares are vested and currently exercisable. The remaining portion of the 9,117-share option will vest over time in equal quarterly installments starting May 4, 2026, subject to continued service.

What is the vesting schedule of Iohan Eran Israel’s NewcelX (NCEL) options?

Beyond the 759 vested shares, the remaining options vest in 11 equal quarterly installments beginning on May 4, 2026. Vesting continues only if he remains in service with NewcelX, linking option benefits to ongoing tenure with the company.

What is the exercise price and expiration date of the NewcelX (NCEL) options?

The reported option grants the right to buy NewcelX ordinary shares at an exercise price of $7.62 per share. The option expires on November 4, 2035, providing a long-term window during which vested portions can potentially be exercised.

Why are NewcelX (NCEL) options held through a trustee for Iohan Eran Israel?

The filing notes that, under NewcelX’s 2021 share option plan, certain employee securities must be registered in a trustee’s name. This structure is designed to qualify for Israeli Section 102 tax benefits, which can provide favorable tax treatment on equity compensation.